Mirae Asset Global Investments Co. Ltd. Raises Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Mirae Asset Global Investments Co. Ltd. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,684 shares of the company's stock after buying an additional 4,236 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in HCA Healthcare were worth $8,111,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Achmea Investment Management B.V. increased its stake in HCA Healthcare by 31.4% in the 1st quarter. Achmea Investment Management B.V. now owns 56,819 shares of the company's stock worth $19,634,000 after acquiring an additional 13,570 shares during the last quarter. Bartlett & CO. Wealth Management LLC increased its position in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. Tranquility Partners LLC increased its position in shares of HCA Healthcare by 1.2% during the 1st quarter. Tranquility Partners LLC now owns 16,645 shares of the company's stock valued at $5,752,000 after purchasing an additional 195 shares during the last quarter. PDS Planning Inc increased its position in shares of HCA Healthcare by 21.7% during the 1st quarter. PDS Planning Inc now owns 1,116 shares of the company's stock valued at $386,000 after purchasing an additional 199 shares during the last quarter. Finally, KG&L Capital Management LLC boosted its holdings in HCA Healthcare by 13.2% during the 1st quarter. KG&L Capital Management LLC now owns 4,086 shares of the company's stock valued at $1,412,000 after acquiring an additional 477 shares during the period. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 1.8%

Shares of HCA stock traded up $6.71 on Tuesday, hitting $389.81. The stock had a trading volume of 1,299,667 shares, compared to its average volume of 1,466,272. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market capitalization of $93.78 billion, a P/E ratio of 17.33, a P/E/G ratio of 1.31 and a beta of 1.49. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The company's 50 day moving average price is $367.86 and its 200-day moving average price is $337.57.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $5.36 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a $0.72 dividend. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.74%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HCA. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays set a $416.00 price target on HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Guggenheim assumed coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Finally, Wall Street Zen lowered HCA Healthcare from a "buy" rating to a "hold" rating in a report on Friday. Eight equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $395.71.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.